The association between admission systolic blood pressure of heart failure patients with preserved systolic function and mortality outcomes.

Link to article at PubMed

Related Articles

The association between admission systolic blood pressure of heart failure patients with preserved systolic function and mortality outcomes.

Eur J Intern Med. 2015 Oct 30;

Authors: Rosman Y, Kopel E, Shlomai G, Goldenberg I, Grossman E

Abstract
INTRODUCTION: Heart failure is a major cause of death and disability and poses a significant public health concern. Approximately half of the patients admitted with heart failure, have preserved left ventricular ejection fraction. The association between systolic blood pressure (SBP) and long-term outcome in this group has not been well established.
AIM: The aim of our study is to evaluate the association between admission SBP and short term and long-term mortality outcomes in patients with heart failure and preserved systolic function.
METHODS: 1230 consecutive patients presenting with preserved left ventricular (LV) systolic function (defined as an LV ejection fraction ≥40%) were included in this survey. Patients were divided into quartiles according to admission SBP: low admission SBP (<127mmHg), intermediate admission SBP (128-145mmHg), high admission SBP (146-170mmHg) and very-high admission SBP (>170mmHg). Primary outcome included in hospital, one and four year mortality rates.
RESULTS: Elevated admission SBP was found to be associated with improved short and long-term mortality (HR=0.25 95% CI - 0.09-0.7, p=0.007 and HR=0.7 95% CI - 0.56-0.88, p=0.002 for the highest versus low SBP group, respectively). This finding was most notable in patients with acute heart failure and patients with ejection fraction≥50%.
CONCLUSION: Elevated admission SBP is associated with a favorable short and long-term outcome in patients with heart failure and preserved systolic function.
KEY MESSAGE: Low admission SBP is an independent predictor for short and long-term mortality in patients with HF and PSF.

PMID: 26525208 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *